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Estrogen is a steroid hormone having pleotropic, physiological effects, including the regulation 
of bone metabolism, reproduction, and immune function. It has been shown that when 
estrogen levels are reduced in the postmenopausal period, women are at increased risk of 
diseases such as osteoporosis, certain cancers, heart disease, and autoimmune diseases [1]. 
Most of these health issues have been linked to changes in immune cell function and 
inflammatory status that occur with estrogen deficiency [2]. Recently, interest has increased in 
understanding the influence of biologically active food components on aspects of the immune 
system located within the gut. The gut-associated lymphoid tissue makes up approximately 70% 
of the immune system and represents an important potential target to alter immune responses 
through the diet or dietary supplements.  Certain foods are high in bioactive components 
known as phenolic compounds.  These compounds have an aromatic ring structure and exhibit 
anti-inflammatory and antioxidant properties that could impact systemic immunity.   
Tart cherries are a particularly rich source of phenolic compounds.  Our research group is 
interested in studying the effects of tart cherry and bioactive phenolic compounds on the 
immune response. A series of in-vivo and in-vitro studies were designed and conducted to 
assess the potential of tart cherries to modulate the immune response in scenarios that mimic 
events occurring in estrogen deficiency. The goal of this project was to analyze the effects of 
tart cherry and its phenolic compounds on the gut mucosal immune response. The hypothesis 
that was tested was that supplementation with dietary tart cherry or its isolated phenolic 
compounds would alter the immune function. To test this hypothesis the following aims were 
developed. 
• Aim 1:  To examine the effects of dietary tart cherry supplementation on the 
inflammatory response within key gut-associated lymphoid tissue (GALT) in a mouse 
model of estrogen hormone deficiency.  
 
 
• Aim 2:  To examine how tart cherry polyphenolics affect cell proliferation and 
inflammatory status of epithelial and immune cells.   
 
Aim 1: 
Animals and Experimental Design.  Five-month-old C57BL/6 female mice were randomly 
assigned to three groups. The mice were either Sham-operated where they underwent surgery, 
but the ovaries were left intact, or ovariectomized (OVX) where the ovaries are removed to 
create a model of ovarian 
hormone (i.e., estrogen) 
deficiency. The mice in the 
Sham and one OVX group 
were fed control (AIN-93M) 
rodent diet.  The other OVX 
group was fed AIN-93M diet 
supplemented with 5% tart 
cherry powder (See Figure 
1). All diets were isocaloric, 
isonitrogenous and were 
adjusted for fiber, calcium, 
phosphorous, potassium, and 
vitamin K. Throughout the study animals were weighed on a weekly basis and provided with RO 
water.  The treatment period lasted for 28 days after which the animals were anesthetized, 
exsanguinated and tissues were harvested. In particular, the small intestine was harvested and 
flushed with ice cold saline and one aspect of the gut associated lymph tissues, the Peyer’s 
patches, was excised and snap frozen for future analyses.  
Peyer’s patches represent small regions of immune tissue between the absorptive gut 
enterocytes (i.e., epithelial cells) containing high concentrations M-cells, B-cells, and T-cells. Due 
to the Peyer’s patches potential to facilitate exposures of bioactive food components in the 
lumen to the immune cells, we examined alterations in gene expression of indicators of immune 
cell differentiation and activation.   
Alterations in Gene Expression.  RNA was extracted from the Peyer’s Patches using the Trizol 
method [3](Life Technology). The integrity of the RNA was assessed using spectrometry and gel 
electrophoresis. cDNA was then synthesized, and qRT-PCR was performed to examine key genes 
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Figure 1.  Experimental design for the animal study. 
 
of interest related to pro-inflammatory, anti-inflammatory, and T-cell differentiation functions in 
this tissue.  Gene expression of the anti-
inflammatory mediator, interleukin (IL)-10, was 
upregulated in the cherry supplemented group 
compared to the Sham (P<0.0286) and tended to be 
increased compared to the OVX mice (Figure 2A). No 
statistically significant differences in IL-4 were 
observed due to OVX or diet (data not shown). In 
contrast, OVX increased transforming growth factor 
(TGF)-β expression, a key regulator of T-cell 
differentiation, but with tart cherry supplementation 
TGF-β was decreased (Figure 2B). This reduction in 
TGF-β expression partially normalized to the Sham 
mice. Signal transducer and activator of transcription 
(STAT3), which is downstream of TGF-β and involved 
in T-cell regulation, was upregulated with OVX 
compared to the Sham mice (Figure 2C).  Tart cherry 
supplementation further upregulated STAT3 
expression (p=0.0347). However, STAT5β, which is 
also downstream of TGF-β, was not significantly 
altered by either OVX or dietary treatment (data not 
shown). 
Summary of Findings Related to Aim 1:  These 
findings indicate that cherry supplementation is 
capable of altering inflammatory gene expression in 
an estrogen deficient model by increasing anti-
inflammatory gene expression as well as normalizing 
genes involved in regulating T-cell differentiation.  
The data support the hypothesis that supplementing 
the diet with foods rich in phenolic compounds such 
as tart cherry can favorable alter the gut mucosal 
immune response.  
 
Aim 2: 
Extraction of Tart Cherry Phenolics.  Total polyphenolics were extracted from dried 























































Figure 2.  Alterations in gene expression in (A) 
IL-10, (B) TGF-β, and (C) STAT3 in the Peyer’s 
patches tissues.  Bars represent the mean + 
SE.  Bars that do not share the same 
superscript letter are statistically different 












sonication. The crude extract was then purified on a C-18 cartridge to remove excess 
carbohydrates. The purified sample was then roto-evaporated and re-suspended in Millipore 
water.  The final extract was then filtered in a 0.22 µm filter prior to cell culture. The Folin-
Ciocalteu assay [4] was employed to quantify the total phenolics and to ensure phenolic 
content was not lost during the purification process. 
Cell Culture Experiments.  Caco-2 cells (ATCC), derived from a human colon adenocarcinoma, 
were used as a model of gut epithelial cells.  For each of the following experiments, these cells 
were cultured using Eagle’s Minimum Essential Medium (EMEM; ATCC) supplemented with 20% 
fetal bovine serum (FBS)(Invitrogen) and 1% penicillin/streptomycin antibiototic (Sigma Aldrich) 
solution.  Cells were grown at 37°C with 5% CO2/95% air-humidified atmosphere. Sub-culturing 
was accomplished prior to cells reaching 80% confluence, using 0.25% trypsin–EDTA (Sigma 
Aldrich).  
Experiment 1--Gut Epithelial Cell Proliferation.  Preliminary MTT assays were conducted on 
Caco-2 cells to determine the effects of phenolic compounds extracted from tart cherry powder 
and lipopolysaccharide (LPS; 
E. coli, Sigma Aldrich) on cell 
growth and proliferation.  
Cells were plated at 20,0000 
cells/well and cultured for 
24, 48 or 72 hours.  At each 
time point, the medium was 
aspirated and cells were 
washed twice (250ul PBS). 
Next, 200ul incomplete 
EMEM was added along with 
50ul of MTT to each well. 
Following a 4 hour 
incubation at 37°C the 
media were aspirated, 200 
uL DMSO and 25 uL glycine 
buffer were added and the 
plate read immediately at 
570nm. Doses of phenolic 
compounds (Figure 3) were selected based on the literature and final doses to be used in these 
experiments were determined based on MTT results (i.e., no observed negative effect on cell 
proliferation).  Final doses of phenolics used in subsequent experiments ranged from 0-10 
µg/mL.    
Figure 3.  MTT results from Caco-2 cells treated with doses of tart cherry 
























Experiment 2—Dose-response Study of Phenolic Compounds on Caco-2 Cells.  To determine 
the effects of the cherry phenolic under 
inflammatory conditions (i.e.,  LPS) on 
Caco-2 cells, alterations in gene expression 
and protein abundance associated with 
pro-inflammatory and anti-inflammatory 
mediators as well as T-cell differentiation 
were quantified. Cells were plated at 
400,000 cells/well into 24 well plates (n=24 
wells/treatment group).  Media were 
changed every two days. After 
approximately 9 days in culture, Caco-2 
cells had formed a confluent monolayer 
and were then treated with the purified 
cherry phenolics (PP;  0, 2.5, 5, and 10 
ug/ml) under normal or inflammatory 
conditions (LPS 0 or 1ug/ml).  
Alterations in Gene and Protein 
Expression.  After 24 hours of treatment, 
RNA and protein were extracted.  The RNA 
extraction with Trizol followed the same 
procedure described previously on the 
mouse tissues (Aim 1) and stored until 
cDNA synthesis and qRT-PCR were 
performed. Protein was extracted using 
RIPA buffer, and concentration was 
quantified by Bradford assay.  
Phenolic compounds at all doses evaluated 
down-regulated IL-1β (p < 0.01), a pro-
inflammatory cytokine, in the LPS-treated 
Caco-2 cells (Figure 4A). However, the anti-
inflammatory cytokine, IL-10, was not 
altered by LPS or the phenolic compounds 
at the doses used in this 
experiment(Figure 4B). It should be noted 
that IL-10 abundance was low for all 
treatments. IL-6 which is known to have 
Figure 4.  Effects of cherry phenolic compounds under 
inflammatory conditions (LPS=1 µg/mL) on the relative 
abundance of RNA for (A) IL-1β, (B) IL-10 and (C) IL-6.  Bars 
represent the mean + SE.  Bars that do not share the same 
superscript letter are statistically different from each other 
























































































both pro- and anti- inflammatory effects was suppressed with LPS.  The highest dose of the 
phenolic extract (10 µg/mL) further reduced the relative abundance of IL-6 in Caco-2 cells under 
inflammatory conditions (Figure 4C).   
Two important regulators of T-cell 
differentiation include transforming growth 
factor (T GF)-β and SMAD family member 
(SMAD2). The relative abundance TGF-β RNA 
was decreased with LPS treatment and the 
phenolic extract at all doses failed to alter 
this response (Figure 5A). SMAD2 , which is 
downstream of TGF-β, responded similarly to 
the LPS and phenolics (Figure 5B).  
Experiment 3—Gut Epithelial Cell Response 
and Its Influence on T cells. CACO-2 cells 
were cultured as previously described and 
then treated with cherry extract (0, 2.5, 5, or 
10 µg/mL) for 24 hrs. The medium was then 
removed and fresh medium was added. 
Conditioned medium was collected after 24 
hours of treatment.  Jurkat T-lymphocytes 
(ATCC) were plated at 500,000 cells/well into 
12 well plates with RPMI 1640 media 
supplemented with 10% FBS and 1% 
pen/strep.  The Jurkat cells were incubated 
overnight and then the next day they were 
treated with 15% or 30% conditioned 
media from the Caco-2 cells. After 6 hours, 
cells were activated using a 
PMA/Ionomycin cocktail in DMSO (10 
ng/mL & / 0.5uM; Sigma Aldrich) or vehicle only (n=6wells/ treatment group). All DMSO final 
concentrations were kept below 0.1% per well.  Cell culture supernatant was collected and 
aliquoted 24 hours post stimulation with conditioned media for future interferon-gamma (IFN-
γ) ELISA (R&D Systems) analysis. 
Summary of findings related to Aim 2.  The in-vitro data show phenolic compounds extracted 
from tart cherry decreased the inflammatory response as indicated by reduced IL-1β gene 
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Figure 5. Influence of cherry phenolic compounds on 
the relative abundance of RNA for (A) TGF-β and (B) 
SMAD2 under inflammatory conditions (LPS=1 µg/mL).  
Bars represent the mean + SE.  Bars that do not share 
the same superscript letter are statistically different 





phenolic extract on the anti-inflammatory cytokine IL-10. However, these data only reflect 
changes in transcription, and should be confirmed with protein assays. Interestingly, the 
response of IL-6 was unanticipated.  Due to this cytokines potential for pro- or anti- 
inflammatory effects, further experiments are needed to understand the role of IL-6 in this 
system. The transcriptional changes in TGF-β and SMAD2 raise the question of whether or not 
the epithelial cell response to the phenolics will alter or influence T-cell activation and 
differentiation. Additional studies will be required to confirm if dietary phenolic compounds’ 
effects on gut epithelial cells alter the gut mucosal immune response.  
Suggested Future Work: 
Future work will include the evaluation of the protein response in the pro- and anti- 
inflammatory mediators as well as key regulators of T-cell differentiation in samples collected 
from both the animal and cell culture studies. These analyses will be used to confirm changes 
observed transcriptionally. Conditions for Experiment 3 need to be optimized and may require 
repeating the cell culture experiments. Prior to the completion of the overall study, PCR 
analysis will be performed on another gut associated lymphoid tissue(GALT), the lamina 
propria, and histological evaluation of the colon and small intestine will be completed.  
Publication Plans: 
These data, in part, were presented in a paper in the biomedical category during the 2015 OSU 
Research Symposium and at the 2016 Experimental Biology Meeting in San Diego, California. 
Additionally, the findings of this study will be combined with metagenomic data into a 
manuscript to be submitted to a nutrition or biomedical journal.  The anticipated submission 
date for the manuscript is spring 2017.  
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